id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0379-0007,FDA,FDA-2011-E-0379,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:27:04Z,,0,0,090000648119d57e
FDA-2011-E-0379-0006,FDA,FDA-2011-E-0379,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-09T04:00:00Z,2012,4,2012-04-09T04:00:00Z,,2012-04-09T12:38:05Z,,0,0,0900006480feb75d
FDA-2011-E-0379-0005,FDA,FDA-2011-E-0379,Determination of Regulatory Review Periods for Posposes pf Patent Extension: NATROBA,Notice,General Notice,2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,2012-05-06T03:59:59Z,2014-02-28T18:26:02Z,2012-08337,0,0,0900006480feab8f
FDA-2011-E-0379-0004,FDA,FDA-2011-E-0379,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-03-12T04:00:00Z,2012,3,2012-03-12T04:00:00Z,,2012-03-13T11:59:52Z,,0,0,0900006480fd3b30